Annual Shareholders Equity
$117.35 M
-$105.01 M-47.23%
31 December 2023
Summary:
Inovio Pharmaceuticals annual stockholders equity is currently $117.35 million, with the most recent change of -$105.01 million (-47.23%) on 31 December 2023. During the last 3 years, it has fallen by -$343.79 million (-74.55%). INO annual shareholders equity is now -74.55% below its all-time high of $461.14 million, reached on 31 December 2020.INO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$73.54 M
-$23.20 M-23.98%
30 September 2024
Summary:
Inovio Pharmaceuticals quarterly stockholders equity is currently $73.54 million, with the most recent change of -$23.20 million (-23.98%) on 30 September 2024. Over the past year, it has dropped by -$64.62 million (-46.77%). INO quarterly shareholders equity is now -87.36% below its all-time high of $581.61 million, reached on 31 March 2021.INO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.2% | -46.8% |
| 3 y3 years | -74.5% | -83.8% |
| 5 y5 years | +35.0% | +118.3% |
INO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.5% | at low | -83.8% | at low |
| 5 y | 5 years | -74.5% | +3316.2% | -87.4% | +2040.8% |
| alltime | all time | -74.5% | +3316.2% | -87.4% | +2465.0% |
Inovio Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $73.54 M(-24.0%) |
| June 2024 | - | $96.74 M(+2.4%) |
| Mar 2024 | - | $94.44 M(-19.5%) |
| Dec 2023 | $117.35 M(-47.2%) | $117.35 M(-15.1%) |
| Sept 2023 | - | $138.16 M(-18.4%) |
| June 2023 | - | $169.37 M(-15.0%) |
| Mar 2023 | - | $199.21 M(-10.4%) |
| Dec 2022 | $222.36 M(-44.4%) | $222.36 M(-16.6%) |
| Sept 2022 | - | $266.70 M(-10.4%) |
| June 2022 | - | $297.67 M(-16.2%) |
| Mar 2022 | - | $355.08 M(-11.2%) |
| Dec 2021 | $399.67 M(-13.3%) | $399.67 M(-11.9%) |
| Sept 2021 | - | $453.57 M(-10.8%) |
| June 2021 | - | $508.55 M(-12.6%) |
| Mar 2021 | - | $581.61 M(+26.1%) |
| Dec 2020 | $461.14 M(>+9900.0%) | $461.14 M(+42.4%) |
| Sept 2020 | - | $323.90 M(+73.9%) |
| June 2020 | - | $186.26 M(+1.1%) |
| Mar 2020 | - | $184.32 M(+5265.9%) |
| Dec 2019 | $3.44 M(-96.0%) | $3.44 M(-89.8%) |
| Sept 2019 | - | $33.69 M(-37.2%) |
| June 2019 | - | $53.62 M(-31.2%) |
| Mar 2019 | - | $77.91 M(-10.4%) |
| Dec 2018 | $86.94 M(-38.9%) | $86.94 M(-16.1%) |
| Sept 2018 | - | $103.61 M(-7.0%) |
| June 2018 | - | $111.40 M(-1.4%) |
| Mar 2018 | - | $113.00 M(-20.6%) |
| Dec 2017 | $142.39 M(+15.5%) | $142.39 M(-12.1%) |
| Sept 2017 | - | $162.02 M(+31.3%) |
| June 2017 | - | $123.43 M(+16.6%) |
| Mar 2017 | - | $105.85 M(-14.1%) |
| Dec 2016 | $123.28 M(-29.8%) | $123.28 M(-16.1%) |
| Sept 2016 | - | $146.88 M(-9.3%) |
| June 2016 | - | $161.99 M(-5.3%) |
| Mar 2016 | - | $170.97 M(-2.7%) |
| Dec 2015 | $175.69 M(+58.0%) | $175.69 M(-9.0%) |
| Sept 2015 | - | $193.14 M(+7.0%) |
| June 2015 | - | $180.56 M(+75.1%) |
| Mar 2015 | - | $103.12 M(-7.3%) |
| Dec 2014 | $111.23 M(+112.0%) | $111.23 M(-4.7%) |
| Sept 2014 | - | $116.73 M(-4.2%) |
| June 2014 | - | $121.84 M(-5.4%) |
| Mar 2014 | - | $128.74 M(+145.4%) |
| Dec 2013 | $52.45 M(+52.7%) | $52.45 M(-15.1%) |
| Sept 2013 | - | $61.76 M(+111.5%) |
| June 2013 | - | $29.20 M(-26.9%) |
| Mar 2013 | - | $39.93 M(+16.2%) |
| Dec 2012 | $34.35 M(-27.4%) | $34.35 M(+11.7%) |
| Sept 2012 | - | $30.76 M(-14.1%) |
| June 2012 | - | $35.83 M(-9.7%) |
| Mar 2012 | - | $39.69 M(-16.1%) |
| Dec 2011 | $47.31 M | $47.31 M(-6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $50.75 M(-7.7%) |
| June 2011 | - | $55.01 M(-4.6%) |
| Mar 2011 | - | $57.66 M(+24.0%) |
| Dec 2010 | $46.50 M(-23.2%) | $46.50 M(-8.7%) |
| Sept 2010 | - | $50.92 M(-0.8%) |
| June 2010 | - | $51.33 M(-12.6%) |
| Mar 2010 | - | $58.70 M(-3.1%) |
| Dec 2009 | $60.56 M(+217.0%) | $60.56 M(-10.3%) |
| Sept 2009 | - | $67.53 M(+81.6%) |
| June 2009 | - | $37.19 M(+135.1%) |
| Mar 2009 | - | $15.82 M(-17.2%) |
| Dec 2008 | $19.11 M(-38.4%) | $19.11 M(-9.0%) |
| Sept 2008 | - | $21.00 M(-10.9%) |
| June 2008 | - | $23.57 M(-14.6%) |
| Mar 2008 | - | $27.60 M(-11.1%) |
| Dec 2007 | $31.03 M(+71.0%) | $31.03 M(-4.6%) |
| Sept 2007 | - | $32.53 M(-9.7%) |
| June 2007 | - | $36.02 M(+51.7%) |
| Mar 2007 | - | $23.75 M(+30.8%) |
| Dec 2006 | $18.15 M(-22.7%) | $18.15 M(+14.2%) |
| Sept 2006 | - | $15.89 M(-15.7%) |
| June 2006 | - | $18.86 M(-11.9%) |
| Mar 2006 | - | $21.41 M(-8.8%) |
| Dec 2005 | $23.47 M(+50.9%) | $23.47 M(+98.0%) |
| Sept 2005 | - | $11.86 M(-20.8%) |
| June 2005 | - | $14.97 M(-13.1%) |
| Mar 2005 | - | $17.23 M(+10.8%) |
| Dec 2004 | $15.55 M(+3.3%) | $15.55 M(-19.6%) |
| Sept 2004 | - | $19.35 M(-15.3%) |
| June 2004 | - | $22.84 M(+53.8%) |
| Mar 2004 | - | $14.84 M(-1.4%) |
| Dec 2003 | $15.05 M(+303.9%) | $15.05 M(+68.7%) |
| Sept 2003 | - | $8.92 M(+211.0%) |
| June 2003 | - | $2.87 M(-29.4%) |
| Mar 2003 | - | $4.06 M(+9.0%) |
| Dec 2002 | $3.73 M(-24.9%) | $3.73 M(-29.3%) |
| Sept 2002 | - | $5.27 M(-20.8%) |
| June 2002 | - | $6.65 M(+71.2%) |
| Mar 2002 | - | $3.89 M(-30.7%) |
| Dec 2001 | $4.96 M(-49.8%) | - |
| Sept 2001 | - | $5.61 M(-23.4%) |
| June 2001 | - | $7.32 M(-25.9%) |
| Mar 2001 | - | $9.89 M(+31.0%) |
| Mar 2001 | $9.89 M(-16.4%) | - |
| Dec 2000 | - | $7.55 M(-19.4%) |
| Sept 2000 | - | $9.37 M(-12.4%) |
| June 2000 | - | $10.69 M(-9.7%) |
| Mar 2000 | $11.83 M(+42.5%) | $11.83 M(-9.7%) |
| Dec 1999 | - | $13.10 M(-11.5%) |
| Sept 1999 | - | $14.80 M(-11.9%) |
| June 1999 | - | $16.80 M(+102.4%) |
| Mar 1999 | $8.30 M | $8.30 M(-23.1%) |
| Dec 1998 | - | $10.80 M |
FAQ
- What is Inovio Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual shareholders equity year-on-year change?
- What is Inovio Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Inovio Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of INO is $117.35 M
What is the all time high annual shareholders equity for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual stockholders equity is $461.14 M
What is Inovio Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, INO annual stockholders equity has changed by -$105.01 M (-47.23%)
What is Inovio Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of INO is $73.54 M
What is the all time high quarterly shareholders equity for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly stockholders equity is $581.61 M
What is Inovio Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, INO quarterly stockholders equity has changed by -$64.62 M (-46.77%)